TY  - GEN
AU  - Michallet,Anne-Sophie
AU  - Campidelli,Arnaud
AU  - Lequeu,Helene
AU  - Dilhuydy,Marie-Sarah
AU  - Tournilhac,Olivier
AU  - Fornecker,Luc-Matthieu
AU  - Dupuis,Jehan
AU  - Cymbalista,Florence
AU  - De Guibert,Sophie
AU  - Delmer,Alain
AU  - Vilque,Jean-Pierre
AU  - Ghez,David
AU  - Leblond,Veronique
AU  - Subtil,Fabien
AU  - Feugier,Pierre
AU  - Ysebaert,Loic
TI  - Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
SN  - 1096-8652
PY  - 2017///1208
KW  - Adenine
KW  - analogs & derivatives
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Cardiovascular Diseases
KW  - chemically induced
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - France
KW  - epidemiology
KW  - Gastrointestinal Diseases
KW  - Hematologic Diseases
KW  - Humans
KW  - Infections
KW  - etiology
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Male
KW  - Molecular Targeted Therapy
KW  - Piperidines
KW  - Protein Kinase Inhibitors
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Salvage Therapy
KW  - Treatment Outcome
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ajh.24715
ER  -